On ECHEMI
Home > Drugs > PKU HealthCare Corp., Ltd.
PKU HealthCare Corp., Ltd.
  • Founded in:

    1993-05-18
  • Country:

    China China
  • Address:

    No. 21, Fangzheng Avenue, Shuitu Town, Beibei District, Chongqing
  • Tax NO.:

    91500000450533779H
  • Registered Funds:

    595.987425 yuan
  • Website:

  • Email:

Related Drugs
Hydroxyethyl starch 130/0.4 sodium chloride injection
This product is a compound preparation, its components are: 500ml: 130/0.430g hydroxyethyl starch and 4.5g sodium chloride. The auxiliary materials are medicinal carbon and hydrochloric acid.
Name Description Content CAS NO. Registered Holders
Hydroxyethyl starch 130/0.4

This product is a blood volume expander. Its volume expansion effect and blood dilution effect depend on the molecular weight, degree of substitution, substitution pattern and drug concentration, as well as the dosage and infusion rate.

More

This product is a blood volume expander. Its volume expansion effect and blood dilution effect depend on the molecular weight, degree of substitution, substitution pattern and drug concentration, as well as the dosage and infusion rate.

30g 0
Sodium chloride

This product is a blood volume expander and participates in maintaining blood volume and electrolyte balance.

More

This product is a blood volume expander and participates in maintaining blood volume and electrolyte balance.

4.5g 7647-14-5 43
Clindamycin Palmitate Hydrochloride Granules
The main ingredient of this product is clindamycin palmitate hydrochloride.
Name Description Content CAS NO. Registered Holders
Clindamycin palmitate hydrochloride

This product is a derivative of clindamycin. It has no antibacterial activity in vitro. It is hydrolyzed by esterase in vivo to form clindamycin and exert its antibacterial activity. The mechanism of action of clindamycin is to inhibit the synthesis of bacterial proteins. It mainly acts on Gram-positive cocci and anaerobic infections. It has good antibacterial effects on Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, etc. It is moderately sensitive to Haemophilus influenzae and Neisseria gonorrhoeae. Some erythromycin-resistant Staphylococcus aureus and Staphylococcus epidermidis are still sensitive to this product. It has good antibacterial effects on both Gram-negative and Gram-positive anaerobic bacteria.

More

This product is a derivative of clindamycin. It has no antibacterial activity in vitro. It is hydrolyzed by esterase in vivo to form clindamycin and exert its antibacterial activity. The mechanism of action of clindamycin is to inhibit the synthesis of bacterial proteins. It mainly acts on Gram-positive cocci and anaerobic infections. It has good antibacterial effects on Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, etc. It is moderately sensitive to Haemophilus influenzae and Neisseria gonorrhoeae. Some erythromycin-resistant Staphylococcus aureus and Staphylococcus epidermidis are still sensitive to this product. It has good antibacterial effects on both Gram-negative and Gram-positive anaerobic bacteria.

25507-04-4 18
Clindamycin Palmitate Hydrochloride Granules
The main ingredient of this drug is clindamycin palmitate hydrochloride, whose chemical name is 6-1(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-7(S)-chloro-6,7,8-trideoxy-L-threo-a-D-galactoctinopyranoside-2-palmitate hydrochloride.
Name Description Content CAS NO. Registered Holders
Clindamycin palmitate hydrochloride

This product is a derivative of clindamycin. It is hydrolyzed by esterase in the body to form clindamycin and exert its antibacterial activity. The mechanism of action of clindamycin is to inhibit the synthesis of bacterial proteins. It mainly acts on Gram-positive cocci and anaerobic infections. It has good antibacterial effects on Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, etc., and is moderately sensitive to Haemophilus influenzae and Neisseria gonorrhoeae. Some erythromycin-resistant Staphylococcus aureus and Staphylococcus epidermidis are still sensitive to this product. It has good antibacterial effects on both Gram-negative and Gram-positive anaerobic bacteria.

More

This product is a derivative of clindamycin. It is hydrolyzed by esterase in the body to form clindamycin and exert its antibacterial activity. The mechanism of action of clindamycin is to inhibit the synthesis of bacterial proteins. It mainly acts on Gram-positive cocci and anaerobic infections. It has good antibacterial effects on Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, etc., and is moderately sensitive to Haemophilus influenzae and Neisseria gonorrhoeae. Some erythromycin-resistant Staphylococcus aureus and Staphylococcus epidermidis are still sensitive to this product. It has good antibacterial effects on both Gram-negative and Gram-positive anaerobic bacteria.

25507-04-4 18
Vitamin E soft capsules
The main ingredient of each capsule of this product is vitamin E. The auxiliary material is refined edible vegetable oil.
Name Description Content CAS NO. Registered Holders
Vitamin E

Participate in some metabolic reactions in the body. It can fight against the peroxidation of free radicals, resist aging, protect the skin, enhance ovarian function, and prevent habitual abortion.

More

Participate in some metabolic reactions in the body. It can fight against the peroxidation of free radicals, resist aging, protect the skin, enhance ovarian function, and prevent habitual abortion.

2074-53-5 11
Kitasamycin Tablets
Kitasamycin
Name Description Content CAS NO. Registered Holders
Sineptina

This product is a macrolide antibiotic. Its mechanism of action is similar to that of erythromycin, and its antibacterial spectrum is also similar to that of erythromycin, but its antibacterial activity against most Gram-positive bacteria is slightly worse. Some erythromycin-resistant Staphylococcus aureus are still sensitive to kitasamycin. This product also has considerable activity against diphtheria, tetani, Neisseria gonorrhoeae, pertussis, Rickettsia and Chlamydia trachomatis.

More

This product is a macrolide antibiotic. Its mechanism of action is similar to that of erythromycin, and its antibacterial spectrum is also similar to that of erythromycin, but its antibacterial activity against most Gram-positive bacteria is slightly worse. Some erythromycin-resistant Staphylococcus aureus are still sensitive to kitasamycin. This product also has considerable activity against diphtheria, tetani, Neisseria gonorrhoeae, pertussis, Rickettsia and Chlamydia trachomatis.

1392-21-8 8
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.